ClinicalTrials.gov
public full text
Public Domain
Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.
To assess alterations of EGFR\& Her2neu expression in primary ovarian high grade serous carcinoma and its correlation with other clinicopathological parameters
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical outcomes and prognostic factors of low-grade serous ovarian cancer: A single-centre observational retrospective study#200189
- Immunohistochemical and molecular studies on ovarian cancer progression and prognosis#1015879
- Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.#1059081
- Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO#875125
- Ovarian mixed low- and high-grade serous carcinoma as a synchronous or metachronous phenomenon: A clinicopathologic study of 39 cases.#449961
Record · ID 812440
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive